Literature DB >> 17310861

Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy.

Jose E Martínez-Rodríguez1, Lidia Sabater, Francesc Graus, Alex Iranzo, Joan Santamaria.   

Abstract

An autoimmune-mediated mechanism is considered the most probable etiology for narcolepsy. However, this hypothesis remains unproven. Since narcolepsy is characterized by dysfunction of the hypothalamic hypocretinergic (orexinergic) system, we evaluated the presence of hypothalamic-specific antibodies in sera and CSF of 25 hypocretin-deficient and 6 non-deficient narcoleptic patients by immunohistochemistry and analyzing a screening of a rat cDNA expression hypothalamic library. There was no hypothalamic-specific reactivity in serum or CSF by inmmunohistochemistry. The screening of the hypothalmic library detected some reactive clones but not a common reactivity. Our study did not find any evidence of hypothalamic-specific autoimmunity in narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310861     DOI: 10.1093/sleep/30.1.27

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  8 in total

1.  Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.

Authors:  Stine Knudsen; Poul J Jennum; Jørgen Alving; Søren Paludan Sheikh; Steen Gammeltoft
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

Review 2.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

3.  Characterization of REM sleep without atonia in patients with narcolepsy and idiopathic hypersomnia using AASM scoring manual criteria.

Authors:  Lourdes M DelRosso; Andrew L Chesson; Romy Hoque
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

4.  Genome-wide gene expression profiling of human narcolepsy.

Authors:  Camilla Bernardini; Wanda Lattanzi; Paolo Bosco; Christian Franceschini; Giuseppe Plazzi; Fabrizio Michetti; Raffaele Ferri
Journal:  Gene Expr       Date:  2012

5.  IgG abnormality in narcolepsy and idiopathic hypersomnia.

Authors:  Susumu Tanaka; Makoto Honda
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

6.  HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.

Authors:  Fang Han; Ling Lin; Barbara Schormair; Fabio Pizza; Giuseppe Plazzi; Hanna M Ollila; Sona Nevsimalova; Poul Jennum; Stine Knudsen; Juliane Winkelmann; Cristin Coquillard; Farbod Babrzadeh; Tim M Strom; Chunlin Wang; Michael Mindrinos; Marcelo Fernandez Vina; Emmanuel Mignot
Journal:  Sleep       Date:  2014-10-01       Impact factor: 5.849

Review 7.  Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder.

Authors:  Maria Pia Giannoccaro; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Nat Sci Sleep       Date:  2021-05-11

Review 8.  History of narcolepsy at Stanford University.

Authors:  Emmanuel J M Mignot
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.